Human Breast Milk's Role in Food Allergy Development

Evaluation of Human Breast Milk and Its Role in Early Food Allergen Sensitization in Infants

The goal of this prospective cohort pilot study is to learn about food allergens being passed on in breast milk to breast feeding infants.

The main question[s] it aims to answer are:

  • Will major allergens for milk, egg, and peanut be passed on to infants in breast milk?
  • Will the infants become sensitized to and develop an allergy to the food allergens found in breast milk?
  • Will early introduction interventions prevent the development of these food allergies?

Participants will

  • provide breast milk sample (s) for testing for food allergens
  • Infants will be tested for sensitization via skin prick and blood testing
  • Infants will be challenge with suspected foods to determine allergy and undergo early introduction procedures

Study Overview

Detailed Description

Recruitment of subjects will be open enrollment pregnant or post-partum women with a personal history of atopic disease such as allergic rhinitis/conjunctivitis, asthma, atopic dermatitis (eczema), and/or food allergy who are exclusively breastfeeding.

Mothers will provide a breastmilk sample(s) for testing of allergens to milk, egg, and wheat. Prior to the introduction of solid foods, infants will need to be tested for sensitization to milk, egg, and wheat via skin prick testing and blood allergy testing.

Infants that are negative for sensitization will undergo introduction of these foods per standard practice. Infants that are positive for sensitization will undergo an office food challenge for those foods that they are sensitized to. A positive food challenge is diagnostic for a food allergy and they will be managed according to standard practice. A negative food challenge means that they are not allergic, and they will undergo early introduction protocols and monitored to continued tolerance.

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • League City, Texas, United States, 77573
        • Recruiting
        • Pediatric Sub Specialty Clinic at Bay Colony
        • Contact:
          • Cleavon Covington, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Infants at 4 months of age up to 24 months of age.

Description

Inclusion Criteria:

  1. Pregnant or post-partum females who plan to exclusively breastfeed and their infants who have completed at least 37 weeks of gestation

    1. These are vulnerable populations
    2. Our study involves breastmilk analysis, which we need postpartum mothers to supply.
    3. (Parent) Testing will be done solely on breastmilk samples, with only potential dietary intervention done to the parent postpartum depending on the outcomes of the infant and breastmilk.
    4. (Infant) In order to determine if allergens in breastmilk play a role in food allergen sensitization, we need to test the infants prior to the introduction of solid foods.
  2. Personal history of atopic disease such as allergic rhinitis/conjunctivitis, asthma, food allergies, and atopic dermatitis
  3. Maternal diet must include hen's egg, cow's milk, and wheat products.

Exclusion Criteria:

  1. No maternal history of atopic disease
  2. Exclusive formula feeding
  3. Maternal diet devoid of hen's egg, cow's milk, or wheat, for example, vegan diets and persons with gluten sensitivity.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Breastmilk positive/Infant sensitized
This group is for infants whose mother's breastmilk is found to be positive for allergens to either cow milk, egg, and/or wheat and who are found to be sensitized to one or more of these allergens.
Allergens determined to be sensitized will be brought in for an oral challenge to that food.
Breastmilk positive/Infant not sensitized
This group is for infants whose mother's breastmilk is found to be positive for allergens to either cow milk, egg, and/or wheat and who are found to be not sensitized to the three allergens.
Infants that are not sensitized will have the food introduced to their diet at regular intervals.
Breastmilk negative/Infant sensitized
This group is for infants whose mother's breastmilk is found to be negative for allergens to either cow milk, egg, and/or wheat and who are found to be sensitized to one or more of these allergens.
Allergens determined to be sensitized will be brought in for an oral challenge to that food.
Breastmilk negative/Infant not sensitized
This group is for infants whose mother's breastmilk is found to be negative for allergens to either cow milk, egg, and/or wheat and who are found to be not sensitized to the three allergens.
Infants that are not sensitized will have the food introduced to their diet at regular intervals.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To assess the detection of allergens in human breast milk
Time Frame: Baseline (4 months of age)
A mass spectrometry will be used to detect the allergens. Mass spectrometry is a technique used in the University of Texas Medical Branch (UTMB) laboratory to detect allergens.
Baseline (4 months of age)
To assess breast milk's role in sensitization to allergens
Time Frame: Baseline (4 months of age)
The infant will be skin prick tested for allergens to milk, eggs, and wheat at 4 months, which is the baseline.
Baseline (4 months of age)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of non-sensitized participants
Time Frame: Baseline (4 months of age), 12 months of age, 24 months of age
The infants that are non-sensitized will begin consuming milk, eggs, and wheat, and each well child check visit.
Baseline (4 months of age), 12 months of age, 24 months of age

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 8, 2024

Primary Completion (Actual)

February 19, 2026

Study Completion (Actual)

February 19, 2026

Study Registration Dates

First Submitted

December 23, 2024

First Submitted That Met QC Criteria

January 2, 2025

First Posted (Actual)

January 9, 2025

Study Record Updates

Last Update Posted (Actual)

February 24, 2026

Last Update Submitted That Met QC Criteria

February 20, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Feeding, Exclusive

Clinical Trials on Open Ended Oral Food Challenge

Subscribe